Cyclooxygenase-2 inhibitor prevents radiation-enhanced infiltration of F98 glioma cells in brain of Fischer rat

International Journal of Radiation Biology

Volumn 91, Issue 8, 2015, Pages 624-633

  Desmarais, Guillaume ^a   Charest, Gabriel ^a   Fortin, David ^b   Bujold, Rachel ^a,c   Mathieu, David ^b   Paquette, Benoit ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b Department of Surgery   (Canada)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

cancer cell infi ltration; Cyclooxygenase 2 inhibitor; glioblastoma multiforme; interleukin 1 ; matrix metalloproteinase; radiotherapy

Indexed keywords

ARACHIDONIC ACID; GELATINASE A; INTERLEUKIN 1BETA; MELOXICAM; MESSENGER RNA; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; CYCLOOXYGENASE 2 INHIBITOR; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADVERSE OUTCOME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN RADIATION; BRAIN TISSUE; CANCER INFILTRATION; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; FISCHER 344 RAT; GLIOBLASTOMA; GLIOMA CELL; IN VITRO STUDY; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION INJURY; RAT; SURVIVAL; TUMOR INVASION; ANIMAL; BRAIN NEOPLASMS; DRUG EFFECTS; GLIOMA; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; SKULL IRRADIATION; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; CYCLOOXYGENASE 2 INHIBITORS; GLIOMA; MALE; MICE; NEOPLASM INVASIVENESS; RADIATION TOLERANCE; RATS; RATS, INBRED F344; THIAZINES; THIAZOLES; TREATMENT OUTCOME;

EID: 84941356563     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2015.1043756     Document Type: Article

References (38)

1. Anand AK, Chaudhory AR, Aggarwal HN, Sachdeva PK, Negi PS, Sinha SN, Babu AG, Jena A, Rao A, Chaudhury PS. 2012. Survival outcome and neurotoxicity in patients of high-grade gliomas treated with conformal radiation and temozolamide. J Cancer Res Therapeut 8: 50-56.
2. Berger MS, Hadjipanayis CG. 2007. Surgery of intrinsic cerebral tumors. Neurosurgery 61: 279-304.
3. Bouchard G, Bouvette G, Therriault H, Bujold R, Saucier C, Paquette B. 2013. Pre-irradiation of mouse mammary gland stimulates breast cancer cell migration and development of lung metastases. Br J Cancer 109: 1829-1838.
4. Brandes AA, Tosoni A, Franceschi E, Reni M, Gatta G, Vecht C. 2008. Glioblastoma in adults. Crit Rev Oncol/Hematol 67: 139-152.
5. Burger PC, Dubois PJ, Schold SC Jr, Smith KR Jr, Odom GL, Crafts DC, Giangaspero F. 1983. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58: 159-169.
6. Chakravarti A, Palanichamy K. 2008. Overcoming therapeutic resistance in malignant gliomas: Current practices and future directions. Cancer Res Treatment 139: 173-189.
7. Charest G, Mathieu D, Lepage M, Fortin D, Paquette B, Sanche L. 2009. Polymer gel in rat skull to assess the accuracy of a new rat stereotactic device for use with the Gamma Knife. Acta Neurochirurgica 151: 677-683.
8. Desmarais G, Fortin D, Bujold R, Wagner R, Mathieu D, Paquette B. 2012. Infiltration of glioma cells in brain parenchyma stimulated by radiation in the F98/Fischer rat model. Int J Radiat Biol 88: 565-574.
9. Ding Q, Bai YF, Wang YQ, An RH. 2010. TGF-beta1 reverses inhibition of COX-2 with NS398 and increases invasion in prostate cancer cells. Am J Medical Sci 339: 425-432.
10. Gaspar LE, Fisher BJ, Macdonald DR, LeBer DV, Halperin EC, Schold SC Jr, Cairncross JG. 1992. Supratentorial malignant glioma: Patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys 24: 55-57.
11. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. 2007. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19.
12. Holtz ML, Kindy MS, Craddock S, Moore RW, Pettigrew LC. 1996. Induction of PGH synthase and c-fos mRNA during early reperfusion of ischemic rat brain. Molec Brain Res 35: 339-343.
13. Huang HC, Huang CY, Lin-Shiau SY, Lin JK. 2009. Ursolic acid inhibits IL-1beta or TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC-zeta and downregulating the MMP-9 expression. Molec Carcinogenesis 48: 517-531.
14. Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P. 1996. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci 93: 2317-2321.
15. Kuwata H, Yoshimura M, Sasaki Y, Yoda E, Nakatani Y, Kudo I, Hara S. 2014. Role of long-chain acyl-coenzyme A synthetases in the regulation of arachidonic acid metabolism in interleukin 1beta-stimulated rat fibroblasts. Biochimica Biophys Acta 1841: 44-53.
16. Kyrkanides S, Moore AH, Olschowka JA, Daeschner JC, Williams JP, Hansen JT, Kerry OBanion M. 2002. Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Molec Brain Res 104: 159-169.
17. Larkins TL, Nowell M, Singh S, Sanford GL. 2006. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 6: 181.
18. Lawrence YR, Li XA, el, Naqa I, Hahn CA, Marks LB, Merchant TE, Dicker AP. 2010. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76: S20-27.
19. Lee CW, Lee IT, Lin CC, Lee HC, Lin WN, Yang CM. 2010. Activation and induction of cytosolic phospholipase A2 by IL-1beta in human tracheal smooth muscle cells: Role of MAPKs/p300 and NF-kappaB. J Cellular Biochem 109: 1045-1056.
20. Lemay R, Archambault M, Tremblay L, Bujold R, Lepage M, Paquette B. 2011. Irradiation of normal mouse tissue increases the invasiveness of mammary cancer cells. Int J Radiat Biol 87: 472-482.
21. Li R, Li G, Deng L, Liu Q, Dai J, Shen J, Zhang J. 2010. IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1. Oncol Rep 23: 1553-1559.
22. Liu Q, Li G, Li R, Shen J, He Q, Deng L, Zhang C, Zhang J. 2010. IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. J Neuro-Oncol 100: 165-176.
23. Mangiola A, Anile C, Pompucci A, Capone G, Rigante L, De Bonis P. 2010. Glioblastoma therapy: Going beyond Hercules Columns. Expert Rev Neurotherapeut 10: 507-514.
24. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K. 1994. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci 91: 3228-3232.
25. Merzak A, McCrea S, Koocheckpour S, Pilkington GJ. 1994. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. Br J Cancer 70: 199-203.
26. Moore AH, Olschowka JA, Williams JP, Okunieff P, OBanion MK. 2005. Regulation of prostaglandin E2 synthesis after brain irradiation. Int J Radiat Oncol Biol Phys 62: 267-272.
27. Moravan MJ, Olschowka JA, Williams JP, OBanion MK. 2011. Cranial irradiation leads to acute and persistent neuroinflammation with delayed increases in T-cell infiltration and CD11c expression in C57BL/6 mouse brain. Radiat Res 176: 459-473.
28. Nakada M, Okada Y, Yamashita J. 2003. The role of matrix metalloproteinases in glioma invasion. Frontiers Biosci 8: e261-269.
29. Paquette B, Therriault H, Desmarais G, Wagner R, Royer R, Bujold R. 2011. Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor. Br J Cancer 105: 534-541.
30. Paquette B, Therriault H, Wagner JR. 2013. Role of interleukin-1beta in radiation-enhancement of MDA-MB-231 breast cancer cell invasion. Radiat Res 180: 292-298.
31. Park CM, Park MJ, Kwak HJ, Lee HC, Kim MS, Lee SH, Park IC, Rhee CH, Hong SI. 2006. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res 66: 8511-8519.
32. Smith WL, Dewitt DL. 1996. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 62: 167-215.
33. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Eng J Med 352: 987-996.
34. Tanaka S, Nakamura T, Sumitani K, Takahashi F, Konishi R, Itano T, Miyamoto O. 2009. Stage- and region-specific cyclooxygenase expression and effects of a selective COX-1 inhibitor in the mouse amygdala kindling model. Neurosci Res 65: 79-87.
35. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. 2001. Sublethal irradiation promotes migration and invasiveness of glioma cells: Implications for radiotherapy of human glioblastoma. Cancer Res 61: 2744-2750.
36. Xin C, Ren S, Eberhardt W, Pfeilschifter J, Huwiler A. 2007. FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism. Br J Pharmacol 150: 943-950.
37. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. 1993. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron 11: 371-386.
38. Yermakova AV, Rollins J, Callahan LM, Rogers J, OBanion MK. 1999. Cyclooxygenase-1 in human Alzheimer and control brain: Quantitative analysis of expression by microglia and CA3 hippocampal neurons. J Neuropathol Experim Neurol 58: 1135-1146.